Original article

Blood Transfusion - 5 2020 (September-October)

Bacterial contamination of blood products for transfusion in the Democratic Republic of the Congo: temperature monitoring, qualitative and semi-quantitative culture

Authors

Key words: bacterial contamination, blood safety, blood transfusion, Africa South of the Sahara, Democratic Republic of the Congo
Publication Date: 2020-08-06

Abstract

Background - Bacterial contamination of blood for transfusion is rarely investigated in low-income countries. We determined the contamination rate of blood products in the Democratic Republic of the Congo.
Material and methods - In this prospective observational study, blood products in one rural and two urban hospitals (paediatric and general) contained a satellite sampling bag by which blood was sampled for culture in a blood culture bottle (4 mL) and on an agar-coated slide to estimate colony forming units (CFU/mL). Bacteria were identified with biochemical tests and MALDI-TOF (Bruker). Exposure time >10 °C was assessed on a subset of blood products.
Results - In total, 1.4% (41 of 2,959) of blood products were contaminated with 48 bacterial isolates. Skin (e.g., Staphylococcus spp.) and environmental (e.g., Bacillus spp.) bacteria predominated (97.8% of 45 isolates identified). Bacterial counts were ≤10³ CFU/mL. Contamination rates for the urban paediatric, urban general and rural hospitals were 1.6%, 2.4% and 0.3%, respectively (p=0.004). None of the following variables was significantly associated with contamination: (i) donor type (voluntary 1.6%, family 1.2%, paid 3.9%); (ii) type of blood product (red cells 1.6%, whole blood 0.6%); (ii) season (dry season 2.4%, rainy season 1.8%); (iv) age of blood product (contaminated 8 days vs non-contaminated 6 days); and (v) exposure time >10 °C (median for contaminated and non-contaminated blood reached maximum test limit of 8 hours).
Discussion - A bacterial contamination rate of 1.4% of whole blood and red cells is similar to results from high-income countries. Implementation of feasible risk-mitigation measures is needed.

References

Downloads

Authors

Anne-Sophie Heroes Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium

Natacha Ndalingosu Centre National de Transfusion Sanguine, Hemovigilance Department, Kinshasa, Democratic Republic of the Congo

Jocelyne Kalema Institut National de Recherche Biomédicale, Department of Microbiology, Kinshasa, Democratic Republic of the Congo; Cliniques Universitaires, Department of Clinical Biology, Kinshasa, Democratic Republic of the Congo

Aimée Luyindula Hôpital Saint-Luc, Blood bank, Kisantu, Democratic Republic of the Congo

Dorothée Kashitu Hôpital Provincial Général de Référence, Blood bank, Kinshasa, Democratic Republic of the Congo

Catherine Akele Hôpital Pédiatrique Kalembe Lembe, Head Office, Kinshasa, Democratic Republic of the Congo

Jeff Kabinda Centre National de Transfusion Sanguine, Head Office, Kinshasa, Democratic Republic of the Congo; Université Pédagogique Nationale, Department of Health Science, Kinshasa, Democratic Republic of the Congo

Katrien Lagrou KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium; University Hospitals Leuven, Department of Laboratory Medicine and National Reference Centre for Mycosis, Leuven, Belgium

Philippe Vandekerckhove Belgian Red Cross-Flanders, Blood service, Mechelen, Belgium; KU Leuven, Department of Public Health and Primary Care, Leuven, Belgium

Jan Jacobs Institute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium

Octavie Lunguya Institut National de Recherche Biomédicale, Department of Microbiology, Kinshasa, Democratic Republic of the Congo; Cliniques Universitaires, Department of Clinical Biology, Kinshasa, Democratic Republic of the Congo

  • Abstract viewed - 820 times
  • PDF downloaded - 260 times